HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John I Gallin Selected Research

Chronic Granulomatous Disease

3/2021Granulibacter bethesdensis, a Pathogen from Patients with Chronic Granulomatous Disease, Produces a Penta-Acylated Hypostimulatory Glycero-D-talo-oct-2-ulosonic Acid-Lipid A Glycolipid (Ko-Lipid A).
2/2021Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
1/2019NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis.
1/2018Inherited p40phox deficiency differs from classic chronic granulomatous disease.
1/2017NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous Disease.
1/2017Early Intracellular Trafficking of Granulibacter bethesdensis in Human Macrophages.
3/2016Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy.
11/2015Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease.
4/2015Common severe infections in chronic granulomatous disease.
1/2015An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John I Gallin Research Topics

Disease

24Chronic Granulomatous Disease
03/2021 - 03/2002
7Infections
10/2016 - 03/2003
7Inflammation (Inflammations)
11/2015 - 03/2002
4Reinfection
04/2015 - 03/2003
4Bacterial Infections (Bacterial Infection)
11/2010 - 06/2003
3Neutropenia
01/2021 - 05/2007
3Liver Abscess
01/2018 - 03/2007
3Mycoses (Diseases, Fungus)
03/2016 - 06/2003
3Granuloma
08/2013 - 01/2005
2Abscess
01/2018 - 06/2008
2Job Syndrome (Hyper-IgE Syndrome)
06/2013 - 10/2007
1COVID-19
11/2021
1Fatigue
01/2021
1Astrocytoma (Pilocytic Astrocytoma)
01/2021
1Diarrhea
01/2021
1Hypotension (Low Blood Pressure)
01/2019
1Capillary Leak Syndrome
01/2019
1Blister (Bulla)
01/2018
1Neoplasms (Cancer)
09/2017
1Thrombosis (Thrombus)
01/2017
1Hypertension (High Blood Pressure)
12/2014
1Atherosclerosis
12/2014
1Cardiovascular Diseases (Cardiovascular Disease)
12/2014
1Pyoderma Gangrenosum
06/2012
1Pyogenic arthritis, pyoderma gangrenosum, and acne
06/2012
1Pneumococcal Infections
11/2010
1Autoimmune Diseases (Autoimmune Disease)
11/2008
1Splenomegaly
06/2008
1Furunculosis (Boils)
10/2007
1Dermatitis
10/2007
1Cysts
10/2007
1Pneumonia (Pneumonitis)
10/2007
1Thymoma (Thymic Carcinoma)
09/2007
1Exanthema (Rash)
06/2003
1Nocardia Infections
08/2002

Drug/Important Bio-Agent (IBA)

10NADPH Oxidases (NAD(P)H oxidase)IBA
03/2021 - 03/2002
7Superoxides (Superoxide)IBA
08/2013 - 03/2002
6Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2005
6Reactive Oxygen Species (Oxygen Radicals)IBA
11/2015 - 05/2007
5NADP (NADPH)IBA
01/2018 - 09/2010
4Anti-Bacterial Agents (Antibiotics)IBA
10/2016 - 03/2003
4Interferon-gamma (Interferon, gamma)IBA
01/2007 - 08/2002
3Oxidoreductases (Dehydrogenase)IBA
03/2016 - 01/2015
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2005 - 06/2003
2Biomarkers (Surrogate Marker)IBA
11/2021 - 12/2014
2EnzymesIBA
01/2021 - 01/2015
2neutrophil cytosol factor 40KIBA
01/2018 - 12/2010
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
12/2010 - 03/2002
2Immunoglobulin G (IgG)IBA
11/2010 - 06/2008
2Itraconazole (Sporanox)FDA LinkGeneric
01/2007 - 06/2003
2Interleukin-1 (Interleukin 1)IBA
06/2005 - 08/2003
1GlycolipidsIBA
03/2021
1PENTAIBA
03/2021
1AcidsIBA
03/2021
1Lipid AIBA
03/2021
1GelsolinIBA
02/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1Interleukin-10 (Interleukin 10)IBA
01/2018
1C-Reactive ProteinIBA
12/2014
1oxidized low density lipoproteinIBA
12/2014
1HDL LipoproteinsIBA
12/2014
1Immunoglobulins (Immunoglobulin)IBA
08/2013
1B-Cell Activating FactorIBA
08/2013
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
06/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012
1Tryptophan (L-Tryptophan)FDA Link
09/2010
1KynurenineIBA
09/2010
1AntibodiesIBA
11/2008
1Alanine Transaminase (SGPT)IBA
06/2008
1Alkaline PhosphataseIBA
06/2008
1Immunoglobulin E (IgE)IBA
10/2007
1Codon (Codons)IBA
10/2007
1Interleukin-6 (Interleukin 6)IBA
10/2007
1CytokinesIBA
10/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2007
1Fibrinogen (Factor I)FDA Link
10/2007
1Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2007
1GliotoxinIBA
09/2007
1PhosphatidylserinesIBA
09/2007
1Hydrocortisone (Cortisol)FDA LinkGeneric
09/2007
1Caspase 3 (Caspase-3)IBA
09/2007
1Pharmaceutical PreparationsIBA
03/2007
1Antifungal AgentsIBA
01/2007
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
06/2005
1Phosphotransferases (Kinase)IBA
06/2005
1Interleukin-8 (Interleukin 8)IBA
01/2005
1LipopolysaccharidesIBA
08/2003
1SulfonamidesIBA
08/2002
1Irritants (Vesicants)IBA
03/2002
1Oxidants (Oxidizing Agents)IBA
03/2002
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2002
1Cyclooxygenase InhibitorsIBA
03/2002
1Dihydrotachysterol (AT 10)IBA
03/2002
1Lipoxygenase InhibitorsIBA
03/2002
1Complement System Proteins (Complement)IBA
03/2002

Therapy/Procedure

4Therapeutics
10/2016 - 03/2003
1Continuity of Patient Care
09/2017
1Antibiotic Prophylaxis
11/2010
1Transplantation
05/2004